Universe Pharmaceuticals (UPC) Receivables - Net: 2020-2024
- Universe Pharmaceuticals' Receivables - Net rose 18.39% to $13.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.0 million, marking a year-over-year increase of 18.39%. This contributed to the annual value of $13.0 million for FY2024, which is 18.39% up from last year.
- Universe Pharmaceuticals' Receivables - Net amounted to $13.0 million in Q3 2024, which was down 9.34% from $14.4 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Receivables - Net registered a high of $18.8 million during Q1 2022, and its lowest value of $11.0 million during Q3 2023.
- For the 3-year period, Universe Pharmaceuticals' Receivables - Net averaged around $15.1 million, with its median value being $15.2 million (2022).
- Its Receivables - Net has fluctuated over the past 5 years, first surged by 39.16% in 2021, then tumbled by 31.05% in 2023.
- Quarterly analysis of 5 years shows Universe Pharmaceuticals' Receivables - Net stood at $11.5 million in 2020, then soared by 39.16% to $16.0 million in 2021, then decreased by 0.28% to $16.0 million in 2022, then plummeted by 31.05% to $11.0 million in 2023, then rose by 18.39% to $13.0 million in 2024.
- Its last three reported values are $13.0 million in Q3 2024, $14.4 million for Q1 2024, and $11.0 million during Q3 2023.
